Every earnings call for SUMICHEM — management tone, guidance, KPIs and promise tracking, quarter by quarter.
SUMICHEM · 5 transcripts · Chemicals · latest Q2 FY26Revenue ₹930 cr (−6% YoY); EBITDA Margin 23.4%; PAT ₹178 cr (−8% YoY). H1 FY26 Revenue grew 9% YoY to ₹1,987 crores, while PAT increased 11% YoY to ₹356 crores.
Read full transcript & analysisRevenue ₹3,149 cr (+11% YoY); EBITDA Margin 20.1%; PAT ₹506 cr (+37% YoY). Record annual profitability with FY25 PAT at ₹506 crore, up 37% YoY.
Read full transcript & analysisRevenue ₹998 cr (+9% YoY); EBITDA Margin 24.8%; PAT ₹193 cr (+34% YoY). Revenue for Q2 FY25 reached ₹998 crores, a 9% YoY increase, driven by strong volume growth despite price declines.
Read full transcript & analysisRevenue ₹674 cr (+3% YoY); EBITDA Margin 20.8%; PAT ₹110 cr (+52% YoY). Q4 Revenue at ₹674 crores, up 3% YoY and 24% QoQ, showing signs of recovery.
Read full transcript & analysisRevenue ₹903 cr (−19% YoY); EBITDA ₹188 cr (−32% YoY); EBITDA Margin 20.8%. Revenue for Q2 FY24 stood at ₹903 crores, a decline of 19.4% YoY from ₹1,121 crores.
Read full transcript & analysis